Victoria P. Werth

faculty photo
Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Department: Dermatology

Contact information
Division of Dermatology
Veterans Administration Hospital
University and Woodland Avenues
Philadelphia, PA 19104
Office: 215-823-4208
Fax: 215-823-5171
Education:
BA (Chemistry)
Catholic University, 1976.
MS (Physical Chemistry)
Catholic University, 1976.
M.D. (Medicine)
Johns Hopkins University, 1980.
Permanent link
 

Description of Research Expertise

Photobiology
Tumor necrosis factor
Cutaneous lupus
Glycosaminoglycans
Clinical and translational research in cutaneous autoimmune diseases

Description of Itmat Expertise

Dr. Werth's research is in the area of autoimmune skin diseases, with a focus on cutaneous lupus erythematosus, dermatomyositis, and pemphigus.

Selected Publications

George M, Kreider M, Shah R, Miller Jr W, Merkel PA, Werth VP: Abnormal Pulmonary Function Tests, Interstitial Lung Disease, and Lung Function Decline in Patients with Classic and Clinically Amyopathic Dermatomyositis. Br J Dermatol 176(262-264), 2017.

van Vollenhoven R., …Werth VP: …Remission in SLE, consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis 76(554-561), 2017.

Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, Illei GG, Drappa J, Wang L, Yoo S: Anifrolumab, an Anti-Interferon-Alpha Receptor Monoclonal Antibody, in Moderate to Severe Systemic Lupus Erythematosus. Arthritis & Rheumatol 69(376-386), 2017.

Ang CC, Anyanwu C, Robinson E, Okawa J, Fujimoto M, Hamaguchi Y, Werth VP: Clinical signs associated with an increased risk of interstitial lung disease: a cohort study of 108 patients with dermatomyositis. Br J Dermatol 176(231-233), 2017.

Haber JS, Merola JF, Werth VP: Classifying Discoid Lupus Erythematosus: Background, Gaps, and Difficulties. Int J Womens Derm 13(S62-S66), 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects. J Am Acad Dermatol 76(11-16), 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients. J Am Acad Dermatol 76, 201-207 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health. J Am Acad Dermatol 76(1-9), 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations. J Am Acad Dermatol 76(191-198), 2017.

Tiao J, Feng R, Bird S, Choi JK, MD, Dunham J, George M, Gonzalez-Rivera TC, Kaufman JL, Khan N, Luo JJ, Micheletti R, Payne AS, Price R, Quinn C, Rubin AI, Sreih AG, Thomas P, Okawa J, Werth VP: The Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) Among Dermatologists, Rheumatologists, and Neurologists. Br J Dermatol 176(423-4730), 2017.

back to top
Last updated: 08/10/2017
The Trustees of the University of Pennsylvania